Family summary
Historical shortage references are available across related Tirzepatide presentations from one manufacturer.
- 0 current shortage context pages.
- 12 historical shortage context pages.
- 1 manufacturer represented.
Tirzepatide - Drug Shortage Information
Public shortage context is available across 12 visible exact NDC pages for this generic family.
This family page is organized from FDA/openFDA shortage records and other publicly available source material, then indexed by generic drug name, manufacturer, NDC, and package details for faster browsing.
Common brands and presentations in this family
These exact presentation links are useful for brand-name, size, and NDC-specific searches related to this shortage family.
tirzepatide 15 mg / .5mL Injection 0.5 mL (Mounjaro) - NDC 00002-1457-80Eli Lilly and Company | 4 Syringetirzepatide 12.5 mg / .5mL Injection 0.5 mL (Mounjaro) - NDC 00002-1460-80Eli Lilly and Company | 4 Syringetirzepatide 10 mg / .5mL Injection 0.5 mL (Mounjaro) - NDC 00002-1471-80Eli Lilly and Company | 4 Syringetirzepatide 7.5 mg / .5mL Injection 0.5 mL (Mounjaro) - NDC 00002-1484-80Eli Lilly and Company | 4 Syringetirzepatide 5 mg / .5mL Injection 0.5 mL (Mounjaro) - NDC 00002-1495-80Eli Lilly and Company | 4 Syringe
Exact NDC product pages in this shortage family
Use the exact NDC page when your team needs package-level product details, public shortage references, and the strongest route into RFQ and sourcing workflows. These links open directly to the Drug Shortage Information section for each product page.
Unless explicitly stated in writing, no direct affiliation, sponsorship, or endorsement by individual product manufacturers with Premium Rx National, LLC should be implied. All brand names, trade names, and trademarks are the property of their respective owners and are presented solely for accurate product identification and informational reference.